This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palmowski, M. Articles by Kiessling, F. Search for Related Content PubMed PubMed Citation Articles by Palmowski, M. Articles by Kiessling, F.

Vessel Fractions in Tumor Xenografts Depicted by Flow- or Contrast-Sensitive Three-Dimensional High-Frequency Doppler Ultrasound Respond Differently to Antiangiogenic Treatment

¹ Medical Physics in Radiology, German Cancer Research Center; ² Division of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; ³ Global Drug Discovery, Bayer Schering Pharma AG, Berlin, Germany; and ⁴ Department of Diagnostic Radiology, University of Heidelberg, Heidelberg, Germany

Requests for reprints: Fabian Kiessling, Division of Experimental Molecular Imaging, University of Aachen, Pauwelsstraβe 20, D-52074 Aachen, Germany. Phone: 49-241-8036124; Fax: 49-241-8082442; E-mail: fkiessling{at}ukaachen.de.

Key Words: micro-ultrasound • angiogenesis • therapy effects • Power Doppler • SU11248

High-frequency volumetric Power Doppler ultrasound (HF-VPDU) captures flow-dependent signals in blood vessels and can be used to assess antiangiogenic therapy effects in rodent tumors. However, the sensitivity is limited to vessels larger than capillaries. Contrast-enhanced HF-VPDU reveals all perfused vessels by assessing stimulated acoustic emissions from disintegrating microbubbles. Thus, we investigated whether flow-sensitive and contrast-enhanced HF-VPDU can depict different vessel fractions and assess their early response to antiangiogenic therapy. Mice with A431 tumors were scanned before and after administration of polybutylcyanoacrylate microbubbles by HF-VPDU. Animals received either antiangiogenic treatment (SU11248) or a control substance and were imaged repeatedly over 9 days. At each time point, tumors were removed for immunohistochemical analysis. During growth of untreated tumors, vascularization decreased correspondingly on flow-sensitive and contrast-enhanced scans. Treated tumors showed a significantly (P < 0.05) stronger decline in vascularization than controls, which was more pronounced in contrast-enhanced scans. Surprisingly, whereas vascularization remained low in contrast-enhanced scans, flow-sensitive ultrasound indicated a reincrease after day 6 with a higher vascularization than the controls at day 9. Histologic evaluation indicated that immature vessels degraded markedly on therapy, whereas large mature vessels on the tumor periphery were more therapy resistant and drew closer due to tumor shrinkage. In conclusion, contrast-enhanced HF-VPDU and flow-sensitive HF-VPDU are both capable of assessing the effects of antiangiogenic therapy. Because contrast-sensitive ultrasound is more sensitive for small immature vessels and flow-sensitive ultrasound mostly captures large vessels at the tumor periphery, the combination of both methods can provide evidence of vascular maturity in tumors. [Cancer Res 2008;68(17):7042–9]

This article has been cited by other articles:

				T. Kodama, N. Tomita, S. Horie, N. Sax, H. Iwasaki, R. Suzuki, K. Maruyama, S. Mori, and F. Manabu Morphological study of acoustic liposomes using transmission electron microscopy J. Electron Microsc. (Tokyo), November 11, 2009; (2009) dfp056v1. [Abstract] [Full Text] [PDF]